Innoviva to Present at Jefferies 2016 Healthcare Conference on June 10
(firmenpresse) - SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 06/01/16 -- Innoviva, Inc. (NASDAQ: INVA) today announced that Michael W. Aguiar, Innoviva's President and Chief Executive Officer, will present at the Jefferies 2016 Healthcare Conference on Friday, June 10, at 11:00 a.m. ET at the Grand Hyatt Hotel, New York.
The presentation will be webcast live and can be accessed from Innoviva's website at or from the following link: a replay of the presentation will be available following the presentation for 90 days.
Innoviva, formerly known as Theravance, Inc., is focused on bringing compelling new medicines to patients in areas of unmet need by leveraging its significant expertise in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva's portfolio is anchored by the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®, which were jointly developed by Innoviva and GSK. Under the agreement with GSK, Innoviva is eligible to receive associated royalty revenues from RELVAR®/BREO® ELLIPTA®, ANORO® ELLIPTA® and, if approved and commercialized, VI monotherapy, as well. In addition, Innoviva retains a 15 percent economic interest in future payments made by GSK for earlier-stage programs partnered with Theravance BioPharma, Inc. For more information, please visit Innoviva's website at .
ANORO®, RELVAR®, BREO® and ELLIPTA® are trademarks of the GlaxoSmithKline group of companies.
(INVA-F)
Eric d'Esparbes
Senior Vice President and Chief Financial Officer
650-238-9640
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 01.06.2016 - 20:05 Uhr
Sprache: Deutsch
News-ID 475126
Anzahl Zeichen: 0
contact information:
Town:
SOUTH SAN FRANCISCO, CA
Kategorie:
Drugs
Diese Pressemitteilung wurde bisher 403 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Innoviva to Present at Jefferies 2016 Healthcare Conference on June 10"
steht unter der journalistisch-redaktionellen Verantwortung von
Innoviva (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
